SAN JOSE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX - News), today announced the U.S clearance and release of the BD FACSCanto(TM) II flow cytometry system for in vitro diagnostic (IVD) use.
